Clinical Trials Browser

Mental Disorders, Tuberous Sclerosis

NCT07282158 2026-03-13

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Phase NA Recruiting

25 enrolled

Gynecologic

Mental Disorders, Ovarian Neoplasms

NCT05166694 2026-03-04

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Phase NA Recruiting

1,300 enrolled

Mental Disorders, Neoplasms

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

11 enrolled

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT07216534 2026-02-05

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

Phase NA Not yet recruiting

32 enrolled

Mental Disorders

NCT05520281 2025-12-15

ORPHYS

Phase NA Completed

24 enrolled

Necrophobia, Mental Disorders, Carcinoma, Neoplasms

NCT00690196 2025-11-10

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Phase NA Active not recruiting

90 enrolled

Mental Disorders, Sleep Initiation and Maintenance Disorders, Nervous System Diseases, Sleep Wake Disorders, Dyssomnias

NCT06001723 2025-06-04

A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Survivors

Phase NA Completed

50 enrolled

Mental Disorders, Depression, Neoplasms

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT05837598 2023-08-03

Adapting the Tumor Board Model for Mental Illness and Cancer

Phase NA Unknown

30 enrolled

BreastGastrointestinalHead & NeckThoracic

Mental Disorders, Bipolar Disorder, Breast Neoplasms, Depressive Disorder, Major, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms, Schizophrenia, Urogenital Neoplasms

NCT02970513 2023-03-14

MicrobioPSY

Phase NA Completed

12 enrolled

Gastrointestinal

Mental Disorders, Escherichia coli Infections, Colorectal Neoplasms

NCT05537870 2022-09-23

The Effectiveness of Nurse Navigators in Cancer Care

Phase NA Completed

191 enrolled

Mental Disorders, Neoplasms

NCT05393492 2022-05-26

GREMO-LCA

Phase NA Unknown

77 enrolled

CNS

Mental Disorders, Brain Injuries, Brain Neoplasms, Hypoxia, Brain, Encephalitis, Ischemia, Meningitis, Stroke

NCT04142710 2021-10-07

MAO

Phase NA Completed

732 enrolled

Mental Disorders, Chronic Disease, Diabetes Mellitus, Neoplasms, Vascular Diseases

NCT03430141 2020-09-22

NWHS

Phase NA Completed

2,898 enrolled

Head & Neck

Mental Disorders, Cardiovascular Diseases, Chronic Disease, Diabetes Mellitus, Metabolic Diseases, Neoplasms, Thyroid Diseases

NCT02015806 2016-01-11

REMIND

Phase NA Completed

53,480 enrolled

BreastGenitourinary

Mental Disorders, Breast Neoplasms, Cardiovascular Diseases, Depression, Diabetes Mellitus, Epilepsy, Parkinson Disease, Prostatic Hyperplasia, Medication Adherence

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Phase NA Terminated

100 enrolled

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

NCT00004832 2015-03-25

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

Phase NA Completed

26 enrolled

Mental Disorders, Neurologic Manifestations, Lambert-Eaton Myasthenic Syndrome, Rare Diseases

NCT01403883 2015-01-16

PROSPER

Phase NA Unknown

50 enrolled

Gastrointestinal

Mental Disorders, Rectal Neoplasms

NCT01441674 2014-02-14

AAT

Phase 1/2 Completed

30 enrolled

Feeding and Eating Disorders, Mental Disorders, Learning Disabilities, Neoplasms, Stroke

NCT00004645 2005-06-24

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Phase 3 Unknown

22 enrolled

Mental Disorders, Diffuse Cerebral Sclerosis of Schilder, Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myelitis, Transverse, Neurologic Manifestations, Neuromyelitis Optica, Rare Diseases

Clinical Trials

RAINBOW

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

ORPHYS

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Survivors

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Adapting the Tumor Board Model for Mental Illness and Cancer

MicrobioPSY

The Effectiveness of Nurse Navigators in Cancer Care

GREMO-LCA

MAO

NWHS

REMIND

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

PROSPER

AAT

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone